World News: 13:00 GMT Tuesday 3rd December 2019. [Cidara Therapeutics, Inc. via Globe Newswire via SPi World News]
SAN DIEGO, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will present a poster at the 61 American Society of Hematology (ASH) Annual Meeting & Exposition, which takes place Dec 7-10, 2019, in Orlando, Fl, and will deliver an oral presentation at the 39 Interdisciplinary Meeting on Anti-Infective Chemotherapy, which takes place Dec 16-17, 2019 in Paris.
The presentation at the ASH Annual Meeting will highlight new preclinical data supporting Cidara’s rezafungin program for the prevention of invasive fungal infections. The presentation at the Interdisciplinary Meeting on Anti-Infective Chemotherapy will provide an overview of Cidara’s rezafungin clinical development program for the treatment and prevention of invasive fungal infections.
Title: Rezafungin Prevention of Pneumocystis Pneumonia and Pneumocystis Reactivation Using Different Doses and Durations of Prophylaxis in a Mouse ModelSession: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster IIPresenter: Voon Ong, Ph.D.Date and Time: Sunday, Dec. 8, 2019, from 6:00-8:15 p.m. ESTLocation: Orange County Convention Center, Hall B
Title: Antifungals, What’s New in 2019?Presenter: Taylor Sandison, M.D., M.P.H.Date and Time: Monday, Dec. 16, 2019, from 4:45-6:15 p.m. CETLocation: Palais des Congrès de Paris, Salle 342
INVESTOR CONTACT: Brian RitchieLifeSci Advisors(212) 915-2578
MEDIA CONTACT: Karen O’Shea, Ph.D. LifeSci Public Relations(929) 469-3860
Globe Newswire: 13:00 GMT Tuesday 3rd December 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.